Home > Income Statement > AJANTA PHARMA

AJANTA PHARMA
Revenue

    Back to Income Statement
AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹4,648 Cr₹4,209 Cr₹3,743 Cr₹3,341 Cr₹2,890 Cr

What is the latest Revenue of AJANTA PHARMA ?

The latest Revenue ratio of AJANTA PHARMA is ₹4,648 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹4,648 Cr
Mar2025₹4,209 Cr
Mar2024₹3,743 Cr
Mar2023₹3,341 Cr
Mar2022₹2,890 Cr

How is Revenue of AJANTA PHARMA Trending?

Years Revenue % Change
Mar2026 ₹4,648 Cr
10.44
Mar2025 ₹4,209 Cr
12.45
Mar2024 ₹3,743 Cr
12.02
Mar2023 ₹3,341 Cr
15.62
Mar2022 ₹2,890 Cr -

Compare Revenue of peers of AJANTA PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AJANTA PHARMA ₹42,637.5 Cr -2.2% -4.8% 43.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,539.0 Cr -1.4% -6.6% 7.3% Stock Analytics
DIVIS LABORATORIES ₹247,576.0 Cr 1.2% -2.6% 60% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,251.0 Cr -2% -6.1% 33% Stock Analytics
CIPLA ₹105,290.0 Cr -2.3% -5.8% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹99,752.6 Cr -1.1% 3.8% -5.5% Stock Analytics


AJANTA PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AJANTA PHARMA

-2.2%

-4.8%

43.1%

SENSEX

0.8%

-4.8%

-10.5%


You may also like the below Video Courses